IL15 and inflammatory bowel disease: Accordingly, the treatment of IBD intestinal biopsies with anti-IL-15 blocking antibody reduced inflammation by decreasing either the activation of mononuclear cells in the lamina propria and the proliferation of crypt enterocytes.